EP3455625
AÐFERÐIR VIÐ AÐ SPÁ FYRIR UM GAGNSEMI NÝMÓTEFNAVAKA Í ÓNÆMISMEÐFERÐ
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
10.5.2017EP published:
2.9.2020EP application number:
17726208.6
EP translation filed:
19.10.2020Grant published:
15.11.2020EPO information:
European Patent Register
Max expiry date:
9.5.2037Expiry date:
9.5.2026Next due date:
31.5.2026
Title:
METHODS FOR PREDICTING THE USEFULNESS OF NEOANTIGENS FOR IMMUNOTHERAPY
Timeline
Today
10.5.2017EP application
2.9.2020EP Publication
19.10.2020Translation submitted
15.11.2020Registration published
9.5.2026Expires
Owner
Name:
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbHAddress:
Freiligrathstrasse 12, 55131 Mainz, DE
Name:
BioNTech SEAddress:
An der Goldgrube 12, 55131, Mainz, DE
Inventor
Name:
VORMEHR, MathiasAddress:
55130 Mainz, DE
Name:
SAHIN, UgurAddress:
55116 Mainz, DE
Name:
SCHRÖRS, BarbaraAddress:
55124 Mainz, DE
Name:
LÖWER, MartinAddress:
55131 Mainz, DE
Name:
BOEGEL, SebastianAddress:
67823 Obermoschel, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
PCT/EP2016/060897Date:
13.5.2016Country:
WO
Classification
Categories:
G01N 33/50, G01N 33/68, G01N 33/53
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 17.5.2021
Expires: 9.5.2022
Payer: Patice ehf.
Number: 6
Paid: 16.5.2022
Expires: 9.5.2023
Payer: Patice ehf.
Number: 7
Paid: 22.4.2023
Expires: 9.5.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 19.4.2024
Expires: 9.5.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 9.5.2025
Expires: 9.5.2026
Payer: Árnason Faktor ehf.